These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2386826)

  • 21. [A comparative analysis of the antiblastic and immunodepressive effect of alkylating agents].
    Kovalev IE; Chernov VA; Maĭskaia LM
    Vopr Onkol; 1969; 15(6):62-4. PubMed ID: 5811126
    [No Abstract]   [Full Text] [Related]  

  • 22. [Basic principles and clinical pharmacology of cytostatic treatment].
    Schmidt CG
    Verh Dtsch Ges Inn Med; 1980; 86():337-67. PubMed ID: 7223027
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of cytostatic agents on proteolytic enzymes of human ovary].
    Wagner F; Koob G; Hofmann KD; Preibsch W; Niedner W; Strohbach H
    Zentralbl Gynakol; 1973 Feb; 95(8):253-8. PubMed ID: 4697128
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.
    Ciomei M; Pastori W; Pastori A; de Castiglione R; Gozzini L; Corradi F
    Anticancer Res; 1993; 13(1):75-9. PubMed ID: 8386497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refresher courses in pharmacology. 6. Mechanisms of drug action.
    Jenkins WL
    J S Afr Vet Assoc; 1972 Mar; 43(1):9-12. PubMed ID: 4375718
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study on MGMT assay and tumor individual predictable chemotherapy].
    Zhang YP
    Ai Zheng; 2004 Jun; 23(6):724-34. PubMed ID: 15191682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New alkylating agents: butyrophenone derivatives.
    Galatulas I; Andreani A; Rambaldi M; Bonazzi D; Bossa R
    Anticancer Res; 1986; 6(4):853-5. PubMed ID: 3752962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anticancer chemotherapy. I. Chemicals and action mechanisms].
    Amiel JL
    Nouv Presse Med; 1979 Apr; 8(19):1567-9. PubMed ID: 492974
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence that 3-hydroxyglutaric acid interacts with NMDA receptors in synaptic plasma membranes from cerebral cortex of young rats.
    Rosa RB; Schwarzbold C; Dalcin KB; Ghisleni GC; Ribeiro CA; Moretto MB; Frizzo ME; Hoffmann GF; Souza DO; Wajner M
    Neurochem Int; 2004 Dec; 45(7):1087-94. PubMed ID: 15337308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
    Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug therapy of cancer].
    Brux Med; 1974 Oct; 54(10):583-92. PubMed ID: 4434239
    [No Abstract]   [Full Text] [Related]  

  • 33. ATP-dependent calcium uptake by rat liver plasma membrane vesicles. Effect of alkylating hepatotoxins in vivo.
    Tsokos-Kuhn JO; Todd EL; McMillin-Wood JB; Mitchell JR
    Mol Pharmacol; 1985 Jul; 28(1):56-61. PubMed ID: 4021997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental studies on the action of various cytostatic substances on the growth of aerobic and anaerobic microorganisms].
    Krebs D; Bloss H
    Zentralbl Bakteriol Orig; 1966 Aug; 200(4):468-79. PubMed ID: 4169936
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in the 5-HT-binding sites in the cerebral cortex, striatum and hypothalamus of rats during ageing and under the effect of dopaminergic agents.
    Petkov VD; Petkov VV; Popova J; Konstantinova E
    Acta Physiol Pharmacol Bulg; 1987; 13(1):11-9. PubMed ID: 3039800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
    Wesierska-Gadek J; Gueorguieva M; Schloffer D; Uhl M; Wojciechowski J
    J Cell Biochem; 2003 Aug; 89(6):1222-34. PubMed ID: 12898520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the cytostatic effect of new synthetic carbamoyl esters "in vivo". 1].
    Demetrescu C; Gheorghiu P; Görk E; Chirită C; Mavrodin A; Teitel A
    Pharmazie; 1965 Oct; 20(10):634-6. PubMed ID: 5880091
    [No Abstract]   [Full Text] [Related]  

  • 38. Ultrastructural changes induced by carbazilquinone in L-1210 lymphocytic leukemia cells in mice.
    Fukuda K; Arakawa M; Shindo H
    Gan; 1974 Aug; 65(4):351-8. PubMed ID: 4426479
    [No Abstract]   [Full Text] [Related]  

  • 39. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of immunosuppressive drugs in the allotransplantation reaction between mice differing at the H-3 locus.
    Nouza K
    Folia Biol (Praha); 1966; 12(4):266-77. PubMed ID: 5330212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.